Real-time insights. Smarter decisions. Better trades.
🔍 Search StocksConfidence: 65%
Date: 16-04-2026
Price: $1.970
Last Price: $1.775
Post-Signal Peak Price: $2.110
MINNEAPOLIS, January 25, 2023--(BUSINESS WIRE)--Imricor Medical Systems, Inc. (ASX:IMR) Imricor, the global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation products, is pleased to announce that it has entered into a Memorandum of Understanding (MOU) with GE HealthCare.
Insiders who purchased US$201k worth of Imricor Medical Systems, Inc. (ASX:IMR) shares over the past year recouped some of their losses after price gained 75% last week. The purchase, however, has proven to be a pricey bet, with losses currently totalling US$42k. While insider transactions are not
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done
If you want to know who really controls Imricor Medical Systems, Inc. (ASX:IMR), then you'll have to look at the makeup of its share registry. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. I quite like to see at least
AI Confidence - 65 % model confidence
Imricor Medical Systems Inc develops and commercializes MRI-compatible medical devices for cardiac ablation procedures. The company is positioned in the niche but growing market of MRI-guided electrophysiology, aiming to improve procedural accuracy and patient outcomes compared to traditional fluoroscopy methods.
| Cash Flow | Weak |
| Debt | Low |
| Profitability | Weak |
| Revenue Trend | Uptrend |
| Trend | Bullish |
| Momentum | Moderate |
| RSI Signal | Neutral |
| Support Level | $ 1.80 |
| Resistance Level | $ 2.20 |